J&J’s HIV vaccine fails Phase 3 clinical trial

Norge Nyheter Nyheter

J&J’s HIV vaccine fails Phase 3 clinical trial
Norge Siste Nytt,Norge Overskrifter
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Johnson & Johnson’s experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal...

Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday. J&J’s stock was down 1.1% in trading on Wednesday afternoon. The vaccine was being tested in a Phase 3 clinical trial that enrolled 3,900 men who have sex with men and transgender people in several countries, including the U.S.

... Johnson & Johnson’s JNJ experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal researchers said Wednesday. J&J’s stock was down 1.1% in trading on Wednesday afternoon. The vaccine was being tested in a Phase 3 clinical trial that enrolled 3,900 men who have sex with men and transgender people in several countries, including the U.S.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

MarketWatch /  🏆 3. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

PolitiFact - Magic Johnson did not contract HIV from a contaminated vaccinePolitiFact - Magic Johnson did not contract HIV from a contaminated vaccineJudy Mikovitz, a controversial virologist responsible for anti-vaccine conspiracies, claimed that Magic Johnson contracted HIV in 1991 from a contaminated Hepatitis B vaccine. That’s wildly untrue.
Les mer »

Johnson & Johnson slashes production on COVID vaccine amid drop in demandJohnson & Johnson slashes production on COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Les mer »

Johnson & Johnson slashes production of COVID vaccine amid drop in demandJohnson & Johnson slashes production of COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Les mer »

J&J to discontinue HIV vaccine trialJ&J to discontinue HIV vaccine trialJohnson & Johnson said on Wednesday that it was pulling the plug on a late-stage global trial of an HIV vaccine after the shot was found ineffective at preventing infections.
Les mer »

Global Push to Treat HIV Leaves Children BehindGlobal Push to Treat HIV Leaves Children BehindAWENDO, Kenya — The stories the mothers tell when they gather at the Awendo Health Centre in western Kenya are a catalog of small failures, missed opportunities and devastating consequences. What unites the two dozen or so women who meet periodically, on wooden benches in a bare clinic room or under a tree in the courtyard, is their children: All have HIV. It has been two decades since efforts to prevent the transmission of HIV, the virus that causes AIDS, from mother to child during pregnancy a
Les mer »



Render Time: 2025-03-07 00:15:13